- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04184856
Binges and Neural Variability (BEDVAR)
August 10, 2021 updated by: University Hospital Tuebingen
What is Driving the Binge in Binge Eating Disorder? Variability in Brain Response to Reward and the Escalation of Consumption
People who suffer from binge eating disorder experience recurrent episodes of binge eating.During these episodes, they consume an unusually large amount of food in a short amount of time and experience loss of control over eating.
However, why such binge eating episodes occur is still largely unknown.
This makes it difficult to develop targeted treatments.
In this project, the experimenters are investigating the brain mechanisms that give rise to the disorder.
They hypothesize that the binge eating episodes are due to an increased variability in reward processing, which they will assess repeatedly over days.
They will test this hypothesis using mathematical models based on behavioural and MRI measurements that are related to the processing of rewards.
Study Overview
Study Type
Observational
Enrollment (Actual)
61
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Deutschland (deu)
-
Tübingen, Deutschland (deu), Germany, 72070
- Psychological Institute, University of Tübingen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The control group will consist of residents of the general area around Tübingen, Germany.
BED patients will be recruited mainly from the outpatient clinic of the Department of Clinical Psychology of Tübingen, Germany.
Description
Inclusion Criteria:
- Binge eating disorder diagnosis
- Subsyndromal binge eating (control)
Exclusion Criteria:
- high risk of suicide
- co-occurring psychotic, bi-polar disorders, alcohol/substance dependence within the past six months
- lack of capacity for consent
- medical disorders that would affect weight and ability to participate
- insufficient German language skills (assessment will be in German)
- taking medication that would affect weight
- MRI exclusion criteria
- irremovable metal attached to the body (e.g. piercings)
- irremovable medical devices (e.g. pacemakers)
- any trauma or surgery which may have left ferromagnetic material in the body
- large tattoos
- pregnancy
- claustrophobia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Binge eating disorder (BED) patients
Individuals with BED diagnosis.
|
(Imaging while) performing reward related tasks.
|
non-BED controls
Individuals that do not experience binges
|
(Imaging while) performing reward related tasks.
|
subsyndromal BED controls
individuals that experience binges but do not fulfill the requirements for BED diagnosis.
|
(Imaging while) performing reward related tasks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variability in blood-oxygen-level dependent (BOLD) signalling in the NAcc during effort allocation task
Time Frame: 100 min
|
Variability of BOLD signal in the nucleus accumbens (NAcc) over time and between trials while performing an effort allocation task.
The signal is measured through functional magnetic resonance imaging (fMRI) and variability is determined through model residuals.
|
100 min
|
Trial-to-trial variability in reward seeking in an effort allocation task
Time Frame: 40 min
|
Variability of performance is an intra-individual measure, that is defined by the residuals of a linear mixed effects model of trial-to-trial performance on the effort allocation task.
|
40 min
|
Variability in BOLD signalling in the NAcc for food-cue reactivity
Time Frame: 15
|
Variability of BOLD signal in the NAcc between blocks of food pictures.
The signal is measured through fMRI and variability is determined through model residuals.
|
15
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variability in BOLD signalling in the NAcc during non-food-cue reactivity
Time Frame: 5
|
Variability of BOLD signal in the NAcc between blocks of non-food pictures.
The signal is measured through fMRI and variability is determined through model residuals.
|
5
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Nils B Kroemer, Dr, University Hospital Tuebingen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 6, 2019
Primary Completion (Actual)
May 31, 2021
Study Completion (Actual)
May 31, 2021
Study Registration Dates
First Submitted
October 29, 2019
First Submitted That Met QC Criteria
November 29, 2019
First Posted (Actual)
December 4, 2019
Study Record Updates
Last Update Posted (Actual)
August 11, 2021
Last Update Submitted That Met QC Criteria
August 10, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BEDVAR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Binge-Eating Disorder
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
ShireCompleted
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedBinge-Eating Disorder | Eating Disorders | Eating Behavior | Eating Disorder | Binge Eating Disorder Associated With ObesityBrazil
-
Nova Scotia Health AuthorityCompletedBinge-Eating Disorder | Eating DisorderCanada
-
BioprojetRecruiting
-
Lindner Center of HOPEJazz PharmaceuticalsRecruiting
-
Idorsia Pharmaceuticals Ltd.Completed
-
University of ChicagoTakedaCompleted
Clinical Trials on fMRI
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterWithdrawnBrain TumorsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Brighton & Sussex Medical SchoolRecruitingDepressionUnited Kingdom
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Hospices Civils de LyonUniversity of KonstanzCompleted
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States